Robert S. Radie's most recent trade in Rockwell Medical Inc was a trade of 50,000 Common Stock done . Disclosure was reported to the exchange on May 20, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Rockwell Medical Inc | Robert S. Radie | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2025 | 50,000 | 143,525 (0%) | 0% | 0 | Common Stock | |
Rockwell Medical Inc | Robert S. Radie | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 36,111 | 93,525 (0%) | 0% | 0 | Common Stock | |
Rockwell Medical Inc | Robert S. Radie | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2023 | 24,715 | 134,404 (0%) | 0% | 0 | Common Stock | |
Paratek Pharmaceuticals Inc. | Robert S. Radie | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2023 | 20,000 | 72,250 (0%) | 0% | 0 | Common Stock | |
Rockwell Medical Inc | Robert S. Radie | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2022 | 25,000 | 109,689 (0%) | 0% | 0 | Common Stock | |
Paratek Pharmaceuticals Inc. | Robert S. Radie | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2022 | 20,000 | 52,250 (0%) | 0% | 0 | Common Stock | |
Rockwell Medical Inc | Robert S. Radie | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2021 | 72,857 | 72,857 | - | - | Stock Option (Right to Buy) | |
Rockwell Medical Inc | Robert S. Radie | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2021 | 50,000 | 84,689 (0%) | 0% | 0 | Common Stock | |
Paratek Pharmaceuticals Inc. | Robert S. Radie | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2021 | 9,000 | 32,250 (0%) | 0% | 0 | Common Stock | |
Paratek Pharmaceuticals Inc. | Robert S. Radie | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2021 | 7,000 | 7,000 | - | - | Stock Option (right to buy) |